LY2365109 hydrochloride
CAS No. 1779796-27-8
LY2365109 hydrochloride( —— )
Catalog No. M26285 CAS No. 1779796-27-8
LY2365109 hydrochloride is a potent and selective GlyT1 inhibitor, with an IC50 of 15.8 nM for glycine uptake in cells over-expressing hGlyT1a.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 43 | Get Quote |
|
| 5MG | 72 | Get Quote |
|
| 10MG | 115 | Get Quote |
|
| 25MG | 222 | Get Quote |
|
| 50MG | 335 | Get Quote |
|
| 100MG | 484 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLY2365109 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionLY2365109 hydrochloride is a potent and selective GlyT1 inhibitor, with an IC50 of 15.8 nM for glycine uptake in cells over-expressing hGlyT1a.
-
DescriptionLY2365109 hydrochloride is a potent and selective GlyT1 inhibitor, with an IC50 of 15.8 nM for glycine uptake in cells over-expressing hGlyT1a.(In Vivo):LY2365109 hydrochloride increases seizure thresholds in mice.LY2365109 hydrochloride (0.3-30 mg/kg; p.o.) produces dose-dependent elevations in CSF levels of glycine.
-
In Vitro——
-
In VivoLY2365109 hydrochloride (0.3-30 mg/kg; p.o.) produces dose-dependent elevations in CSF levels of glycine.LY2365109 hydrochloride increases seizure thresholds in mice. Animal Model:Male Sprague-Dawley rats (250-300 g)Dosage:0.3 mg/kg, 1 mg/kg, 5 mg/kg, 10 mg/kg, 30 mg/kg Administration:Oral administrationResult:Produced dose-dependent elevations in CSF levels of glycine measured 1 h after dosing.
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetGlyT
-
RecptorKetohexokinase (KHK)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1779796-27-8
-
Formula Weight421.91
-
Molecular FormulaC22H28ClNO5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 31 mg/mL (73.48 mM)
-
SMILESO=C(O)CN(CCOC1=CC=C(C2=CC=C(OCO3)C3=C2)C=C1C(C)(C)C)C.Cl[H]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Maryanoff BE, et al. Inhibitors of Ketohexokinase: Discovery of Pyrimidinopyrimidines with Specific Substitution that Complements the ATP-Binding Site. ACS Med Chem Lett. 2011 Apr 18;2(7):538-43.
molnova catalog
related products
-
PF-03463275
PF-03463275 (PF 3463275) ia an orally bioavailable, centrally penetrant, potent, reversible, selective, and competitive inhibitor of the human GlyT1 transporter with Ki of 13 nM.
-
Opiranserin
Opiranserin (VVZ-149, VVZ-000149) is a?potent, selective, mixed glycine GlyT2 transporter blocker (IC50= 0.86 uM).
-
Bitopertin
A potent and selective GlyT1 inhibitor with EC50 of 30 nM; no activity for GlyT2, hERG, CYP450 enzymes above 10 uM.
Cart
sales@molnova.com